CILAZAPRIL TEVA 2.5 MG
Country: Israel
Language: English
Source: Ministry of Health
Public Assessment Report
(PAR)
18-08-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CILAZAPRIL
Available from:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
ATC code:
C09AA08
Pharmaceutical form:
TABLETS
Composition:
CILAZAPRIL 2.5 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
Therapeutic group:
CILAZAPRIL
Therapeutic area:
CILAZAPRIL
Therapeutic indications:
Treatment of essential hypertension, renal hypertension and chronic heart failure.
Authorization date:
2012-08-31
